Resmed (RMD) Shares Outstanding (2010 - 2026)

Resmed (RMD) has 17 years of Shares Outstanding data on file, last reported at $190.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding changed 0.39% year-over-year to $190.9 million; the trailing twelve-month figure through Mar 2026 stood at $190.9 million (changed 0.39% YoY), and the FY2025 full-year result was $146.4 million, down 22.78% from the prior year.
• Shares Outstanding for Q1 2026 stood at $190.9 million, roughly flat from $190.8 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $190.8 million in Q4 2025 and bottomed at $145.0 million in Q1 2026.
• The 5-year median for Shares Outstanding is $188.9 million (2023), against an average of $184.2 million.
• The widest annual swing landed in 2022, when Shares Outstanding plunged 122.33%; it then surged 551.19% in 2023.
• A 5-year view of Shares Outstanding shows it stood at $188.7 million in 2022, then gained by 0.28% to $189.3 million in 2023, then rose by 0.42% to $190.0 million in 2024, then increased by 0.4% to $190.8 million in 2025, then advanced by 0.03% to $190.9 million in 2026.
• The last three Shares Outstanding figures came in at $190.9 million (Q1 2026), $190.8 million (Q4 2025), and $190.4 million (Q3 2025), per Business Quant data.

Peer Comparison